• Explore /
  • Poster
  • / Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.

Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143.

Abstract Poster

Authors

null

John H. Sampson

Duke University Medical Center, Durham, NC

John H. Sampson , Gordana Vlahovic , Solmaz Sahebjam , Antonio Marcilio Padula Omuro , Joachim M. Baehring , David A Hafler , Alfredo Daniel Voloschin , Prashni Paliwal , Joseph Grosso , Vlad Coric , Timothy F. Cloughesy , Michael Lim , David A. Reardon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics and Translational Research

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT02017717

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3010)

DOI

10.1200/jco.2015.33.15_suppl.3010

Abstract #

3010

Poster Bd #

336

Abstract Disclosures

Similar Posters

First Author: John Howard Sampson

First Author: Julia Katharina Schwarze

First Author: Julia Katharina Schwarze

First Author: Sapna Pradyuman Patel